Major Bleeding Events Are Stronger Predictors of Long-Term Mortality Than Coronary Events in Secondary Prevention Therapy for Ischaemic Heart Disease

الملخص EN

Background.

Secondary prevention of ischaemic heart disease (IHD) is an important aspect of healthcare.

To improve the prognosis of and control risk factors for IHD patients, we created a unique referral system called the Shizuoka IHD patient registry.

Methods.

From 2009 to 2013, we enrolled 1240 patients; they participated in follow-up until 2018.

The risk factor target values were as follows: low-density-lipoprotein cholesterol, <100 mg/dl; glycated haemoglobin of diabetes patients, <7%; systolic blood pressure, <130 mmHg; and diastolic blood pressure, <80 mmHg (mean follow-up interval, 2001 ± 794 days).

The cumulative incidence rates were 10.8% for all-cause death (cardiac death, 1.5%), 15.7% for coronary events, and 2.6% for major bleeding.

Patients were separated into the major bleeding group (n = 32), coronary event group (n = 195), and event-free group (n = 1013) without overlapping.

Results.

We observed significant differences in age, rate antithrombotic drug use, and mortality.

A Kaplan–Meier analysis of all-cause death showed significant differences between the event-free and major bleeding groups (P=0.002) and between the coronary event and major bleeding groups (P=0.026); there was no significant difference between the event-free and coronary event groups.

Conclusion.

Major bleeding events were stronger predictors of long-term mortality than coronary events during the long-term follow-up of stable IHD.